(Q37242966)

English

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction (English)

1 reference

Europe PubMed Central

19 August 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

Nina Friis-Møller

object named as

N Friis-Moller

4

0 references

Alicja Wiercińska-Drapało

0 references

1 reference

ORCID Public Data File 2021

2

object named as

C A Sabin

1 reference

Europe PubMed Central

19 August 2017

Antonella d'Arminio Monforte

3

object named as

A d'Arminio Monforte

1 reference

Europe PubMed Central

19 August 2017

14

object named as

J D Lundgren

1 reference

Europe PubMed Central

19 August 2017

8

object named as

O Kirk

1 reference

Europe PubMed Central

19 August 2017

7

object named as

P Reiss

1 reference

Europe PubMed Central

19 August 2017

author name string

Data Collection on Adverse Events of Anti-HIV Drugs Study Group

1

1 reference

Europe PubMed Central

19 August 2017

R Weber

5

1 reference

Europe PubMed Central

19 August 2017

W M El-Sadr

6

1 reference

Europe PubMed Central

19 August 2017

P Mercie

9

1 reference

Europe PubMed Central

19 August 2017

M G Law

10

1 reference

Europe PubMed Central

19 August 2017

S De Wit

11

1 reference

Europe PubMed Central

19 August 2017

C Pradier

12

1 reference

Europe PubMed Central

19 August 2017

A N Phillips

13

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

19 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

19 August 2017

46

1 reference

Europe PubMed Central

19 August 2017

7

1 reference

Europe PubMed Central

19 August 2017

1101-1110

1 reference

Europe PubMed Central

19 August 2017

Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

6 September 2017

Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

6 September 2017

Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

6 September 2017

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

6 September 2017

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

6 September 2017

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

6 September 2017

Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

26 June 2018

Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Myocardial infarction in HIV-infected men receiving protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Lipid abnormalities during saquinavir soft-gel-based highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702541

3 September 2018

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1086%2F528862

21 January 2018

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

2 references

https://api.crossref.org/works/10.1086%2F528862

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/18461712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario

1 reference

https://pubmed.ncbi.nlm.nih.gov/18461712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe premature coronary artery disease with protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18461712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

https://api.fatcat.wiki/v0/release/y4kl4f2vgbablbqbmash7p3qya

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_y4kl4f2vgbablbqbmash7p3qya

1 reference

https://api.fatcat.wiki/v0/release/y4kl4f2vgbablbqbmash7p3qya

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/y4kl4f2vgbablbqbmash7p3qya

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/y4kl4f2vgbablbqbmash7p3qya

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37242966&oldid=1801616301"